VEGFA is highly elevated in ascites from human EOC patients, upregulated by lysophosphatidic acid, an oncolipid in EOC, and functionally involved in angiogenesis, tumor growth, metastasis, drug resistance, and vascular permeability [72,73,74,75,76,77,78,79,80,81,82,83]. This evidence concerns the gene VEGFA and neoplasm.